EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Bone Marrow Niche in Cardiometabolic Disease: Mechanisms and Therapeutic Potential

Zachary A Kohutek iD, Heather L Caslin iD, Daniel J Fehrenbach iD, J Brett Heimlich, Jonathan D Brown iD, Meena S Madhur iD, P Brent Ferrell iD, Amanda C Doran iD

Circulation Research · 31.01.2025 · 136 (3) · 325-353

DOI: 10.1161/circresaha.124.323778 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Circulation Research, erschienen am 31.01.2025. Verfasst von Zachary A Kohutek und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology (Z.A.K.), Vanderbilt University Medical Center, Nashville, TN. Hauptthemen laut MEDLINE: Stem Cell Niche, Cardiovascular Diseases, Hematopoietic Stem Cells, Bone Marrow. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 296 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, BLRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular and cardiometabolic diseases are leading causes of morbidity and mortality worldwide, driven in part by chronic inflammation. Emerging research suggests that the bone marrow microenvironment, or marrow niche, plays a critical role in both immune system regulation and disease progression. The bone marrow niche is essential for maintaining hematopoietic stem cells (HSCs) and orchestrating hematopoiesis. Under normal conditions, this niche ensures a return to immune homeostasis after acute stress. However, in the setting of inflammatory conditions such as those seen in cardiometabolic diseases, it becomes dysregulated, leading to enhanced myelopoiesis and immune activation. This review explores the reciprocal relationship between the bone marrow niche and cardiometabolic diseases, highlighting how alterations in the niche contribute to disease development and progression. The niche regulates HSCs through complex interactions with stromal cells, endothelial cells, and signaling molecules. However, in the setting of chronic diseases such as hypertension, atherosclerosis, and diabetes, inflammatory signals disrupt the balance between HSC self-renewal and differentiation, promoting the excessive production of proinflammatory myeloid cells that exacerbate the disease. Key mechanisms discussed include the effects of hyperlipidemia, hyperglycemia, and sympathetic nervous system activation on HSC proliferation and differentiation. Furthermore, the review emphasizes the role of epigenetic modifications and metabolic reprogramming in creating trained immunity, a phenomenon whereby HSCs acquire long-term proinflammatory characteristics that sustain disease states. Finally, we explore therapeutic strategies aimed at targeting the bone marrow niche to mitigate chronic inflammation and its sequelae. Novel interventions that modulate hematopoiesis and restore niche homeostasis hold promise for the treatment of cardiometabolic diseases. By interrupting the vicious cycle of inflammation and marrow dysregulation, such therapies may offer new avenues for reducing cardiovascular risk and improving patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stem Cell NicheCardiovascular DiseasesHematopoietic Stem CellsBone MarrowMetabolic DiseasesHumansAnimalsHematopoiesisInflammation

Stichwörter der Autor:innen

bone marrowcardiovascular diseaseshematopoiesisinflammationmyelopoiesis

Autor:innen und Institutionen

  • Department of Radiation Oncology (Z.A.K.), Vanderbilt University Medical Center, Nashville, TN.
  • Department of Health and Human Performance, University of Houston, TX (H.L.C.).
  • Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis (D.J.F., M.S.M.).
  • Division of Cardiovascular Medicine, Department of Medicine (J.B.H., J.D.B., A.C.D.), Vanderbilt University Medical Center, Nashville, TN.
  • Division of Hematology and Oncology, Department of Medicine (P.B.F.), Vanderbilt University Medical Center, Nashville, TN.
  • Vanderbilt Institute for Infection, Immunology, and Inflammation, Vanderbilt University, Nashville, TN (P.B.F., A.C.D.).

ORCID-Profile: Zachary A Kohutek, Heather L Caslin, Daniel J Fehrenbach, Jonathan D Brown, Meena S Madhur, P Brent Ferrell, Amanda C Doran

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • BLRD VA
  • NIAID NIH HHS

Zitieren

APA

Kohutek, Z. A., Caslin, H. L., Fehrenbach, D. J., Heimlich, J. B., Brown, J. D., Madhur, M. S., Ferrell, P. B., & Doran, A. C. (2025). Bone Marrow Niche in Cardiometabolic Disease: Mechanisms and Therapeutic Potential. Circulation Research, 136(3), 325-353. https://doi.org/10.1161/circresaha.124.323778

Vancouver

Kohutek ZA, Caslin HL, Fehrenbach DJ, Heimlich JB, Brown JD, Madhur MS, et al. Bone Marrow Niche in Cardiometabolic Disease: Mechanisms and Therapeutic Potential. Circulation Research. 2025;136(3):325-353. doi:10.1161/circresaha.124.323778

BibTeX
@article{Kohutek2025,
  author = {Kohutek, Zachary A and Caslin, Heather L and Fehrenbach, Daniel J and Heimlich, J Brett and Brown, Jonathan D and Madhur, Meena S and Ferrell, P Brent and Doran, Amanda C},
  title = {Bone Marrow Niche in Cardiometabolic Disease: Mechanisms and Therapeutic Potential},
  journal = {Circulation Research},
  year = {2025},
  volume = {136},
  number = {3},
  pages = {325--353},
  doi = {10.1161/circresaha.124.323778}
}
Kostenlos starten →